3182
WISE Nasdaq Ovrs CHN NewEcoCom Top50 Tkr
NAV as of
4 Week: 9.79 - 10.87
52 Week: 7.79 - 12.98
Latest Closing Price
10.13
Premium / Discount
-1.37
Expense Ratio
0.6%
Investment Objective
The Sub-Fund is an index-tracking fund which seeks to track the performance of the
Main Fund Characteristics
Performance
Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
---|---|---|---|
YTD | -8.74 | 1.73 | -5.06 |
1 Day | 3.47 | 0.00 | 0.00 |
1 Week | -0.69 | 5.20 | -0.13 |
1 Month | -3.34 | 7.47 | -0.45 |
3 Months | 1.86 | 13.79 | 0.13 |
6 Months | -8.08 | 18.11 | -0.45 |
1 Year | 4.16 | 36.11 | 0.12 |
2 Years | -37.00 | 57.43 | -0.64 |
3 Years | -33.27 | 66.92 | -0.50 |
5 Years | 0.00 | 0.00 | 0.00 |
10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 26.5764 | 78.1711 | -25.9388 | -24.0599 |
Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 40.0000 | 3.0000 | 95.0000 | 45.0000 |
Dividend Frequency
Lastest Dividend
Ex Date | Payment Date | Dividend Payout per unit |
---|---|---|
N.A |
Portfolio Data
Total Number of Holdings: 50
Number of Bond Holdings: 0
Number of Equity Holdings: 49
Total Market Value: 16,853,141
Portfolio Composition
Top 10 Holdings
% Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
---|---|---|---|---|---|
1 | Pinduoduo Inc ADR | 9.2403 | 1,212 | -712 | 1,557,287 |
2 | Meituan | 7.6002 | 3,600 | 3,600 | 1,280,880 |
3 | Tencent Holdings Ltd | 7.2788 | 1,800 | -1,600 | 1,226,700 |
4 | JD.com Inc ADR | 6.4308 | 1,576 | -2,088 | 1,083,798 |
5 | Alibaba Group Holding Ltd ADR | 5.0567 | 433 | -491 | 852,213 |
6 | BYD Co Ltd ADR | 4.5781 | 3,250 | -6,250 | 771,550 |
7 | Baidu Inc ADR | 3.7629 | 348 | -484 | 634,164 |
8 | NetEase Inc ADR | 3.7033 | 700 | -1,210 | 624,131 |
9 | NIO Inc ADR | 3.6164 | 1,379 | -929 | 609,476 |
10 | WuXi Biologics (Cayman) Inc ADR | 2.9131 | 4,500 | -6,000 | 490,950 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
Size | % of portfolio |
---|---|
Giant | 72.88 |
Large | 27.02 |
Medium | 0.00 |
Small | 0.00 |
Micro | 0.00 |
Equity Style Box Breakdown
0 | 0 | 0 | Large |
0 | 0 | 0 | Mid |
0 | 0 | 0 | Small |
Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
37.0654
Price/Book*
5.1403
Price/Sales*
3.5432
Price/Cash Flow*
20.9805
Dividend Yield*
0.3110
Growth Measures
Long-Term Earnings
24.2876
Historical Earnings
-6.1980
Sales Growth
6.9110
Cash-Flow Growth
-0.4856
Book-Value Growth
13.9761
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
Detail | Value |
---|---|
Average Effective Duration | 0 |
Average Effective Maturity (Years)* | 0 |
Average Credit Quality | 0 |
Average Weighted Coupon* | 0 |
Average Weighted Price* | 0 |
Bond Style Box Breakdown
0 | 0 | 0 | High | Quality |
0 | 0 | 0 | Med | |
0 | 0 | 0 | Low | |
Ltd | Mod | Ext | ||
Interest-Rate Sensitivity |
Credit Quality
Type | % Bonds |
---|---|
N.A |
Bond Sector
Bond Maturity
% Bonds | |
---|---|
N.A |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.